Selection of patients before and after anticancer treatment for ovarian cryopreservation | Zendy

Ronit Abir | Zendy; Avi BenHaroush | Zendy; Carmela Felz | Zendy; E Okon | Zendy; Hila Raanani | Zendy; Raoul Orvieto | Zendy; Shmuel Nitke | Zendy; Benjamin Fisch | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Selection of patients before and after anticancer treatment for ovarian cryopreservation

Author(s) -

Ronit Abir,

Avi BenHaroush,

Carmela Felz,

E Okon,

Hila Raanani,

Raoul Orvieto,

Shmuel Nitke,

Benjamin Fisch

Publication year - 2008

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/dem413

Subject(s) - cryopreservation , antral follicle , ovarian tissue cryopreservation , andrology , follicular phase , fertility preservation , ovarian follicle , chemotherapy , ovary , biology , folliculogenesis , premature ovarian failure , ovarian cancer , oocyte cryopreservation , oocyte , medicine , oncology , endocrinology , cancer , embryo , fertility , population , environmental health , microbiology and biotechnology

Although ovarian cryopreservation in patients with cancer should ideally be performed before the initiation of therapy, cryopreservation from such patients often becomes an option only later. The justification for the procedure needs to be elucidated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research